Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta‐Piccoli, et al.
Clinical Reviews in Allergy & Immunology (2017) Vol. 54, Iss. 1, pp. 147-176
Closed Access | Times Cited: 302

Showing 26-50 of 302 citing articles:

A Case of Suspected Homeopathy-Induced Stevens–Johnson Syndrome in a Pediatric Patient From Bangladesh
Nahian Rabby, SOUMYADIPTO BISWAS ARKO, Utsow Saha, et al.
Cureus (2025)
Open Access
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
Cristina Scavone, Cristina Di Mauro, Rosanna Ruggiero, et al.
Drugs - Real World Outcomes (2019) Vol. 7, Iss. 1, pp. 41-51
Open Access | Times Cited: 34
Toxic epidermal necrolysis associated with pembrolizumab
Zhuo Ran Cai, Julie Lecours, Jean‐Philippe Adam, et al.
Journal of Oncology Pharmacy Practice (2019) Vol. 26, Iss. 5, pp. 1259-1265
Closed Access | Times Cited: 32
Toxic Epidermal Necrolysis in a Critically Ill African American Woman: A Case Report Written With ChatGPT Assistance
Rebekah Lantz
Cureus (2023)
Open Access | Times Cited: 10
A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drugs in Dentistry
Anna Kotowska-Rodziewicz, Anna Zalewska, Mateusz Maciejczyk
Medical Science Monitor (2023) Vol. 29
Open Access | Times Cited: 10
Clinical, Therapeutic, and Evolutionary Aspects of Stevens-Johnson Syndrome and Lyell's Syndrome in the Pediatric Department of the University Hospital Center of Libreville: Report of Two Clinical Cases
Loembe FC, M. El, Angela Mekame, et al.
Asian Journal of Pediatric Research (2025) Vol. 15, Iss. 1, pp. 9-15
Open Access
Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance
Katlyn M Smaha, Nadia N Talebi, Jennifer L. Waller, et al.
The American Journal of the Medical Sciences (2025)
Closed Access
Updated Insights on Levetiracetam-Associated Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis
Zhanshen Wu, Yang Zhao, Xiangyu Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Clarithromycin induced Stevens-Johnson syndrome in the oral cavity: Case report
Vasileios Zisis, Stefanos Zisis, Konstantinos Poulopoulos, et al.
Balkan Journal of Dental Medicine (2025) Vol. 29, Iss. 1, pp. 72-76
Open Access
A case of RIME syndrome of pneumonia caused by atypical pathogens
R. F. Sayfullin, K. A. Kiseleva, M. A. Butor, et al.
CHILDREN INFECTIONS (2025) Vol. 24, Iss. 1, pp. 63-67
Open Access
Role of basophils and type 2 inflammation in bullous pemphigoid pathophysiology: a comparative study of blood and blister fluid
B Su, Quanhong Zhang, Xiaopeng Hu, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Closed Access
Adalimumab combination with corticosteroid therapy for Stevens–Johnson syndrome/toxic epidermal necrolysis
Jia Liu, Mengyun Zhou, Taoye Li, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
A Case of Stevens–Johnson Syndrome Induced by Selpercatinib
Yuki Tone, Mami Matsui, A. Park, et al.
The Journal of Dermatology (2025)
Closed Access
Stevens–Johnson syndrome/toxic epidermal necrolysis overlap syndrome due to a fixed-dose combination of aceclofenac, serratiopeptidase, and paracetamol
Chaitali Chindhalore, Ganesh Natthuji Dakhale, Tamil Selvi Emperumal, et al.
National Journal of Pharmacology and Therapeutics (2025) Vol. 3, Iss. 1, pp. 69-71
Closed Access
Síndrome de Steven Jhonson / Necrólisis epidérmica tóxica: revisión de literatura y actualización
J. Martínez, Daysi Lorena Daysi Lorena Caiza López, Roberto José Bonfante Villalobos, et al.
Medicina (2025) Vol. 46, Iss. 3, pp. 729-741
Open Access
Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions
Dean J. Naisbitt, Anna Olsson‐Brown, Andrew Gibson, et al.
Allergy (2019) Vol. 75, Iss. 4, pp. 781-797
Open Access | Times Cited: 29
Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis
Christopher Pham, T. Justin Gillenwater, Eric S. Nagengast, et al.
Burns (2019) Vol. 45, Iss. 7, pp. 1634-1638
Closed Access | Times Cited: 28
Stevens‐Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases
Ana V. Pejčić
International Journal of Dermatology (2020) Vol. 60, Iss. 1, pp. 12-24
Closed Access | Times Cited: 24
GenotypingHLAalleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
Thawinee Jantararoungtong, Therdpong Tempark, Napatrupron Koomdee, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 9, pp. 1049-1064
Open Access | Times Cited: 21
The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine
Edward Stanley, Lois Zhang, Justine O’Hara, et al.
Burns (2023) Vol. 50, Iss. 1, pp. 87-92
Closed Access | Times Cited: 9
Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification
Blake McKinley, Mitchell Edger Allen, Nicole Michels
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Effect of Early Cyclosporine Treatment on Survival in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Atsushi Senda, Kiyohide Fushimi, Koji Morishita
Cureus (2024)
Open Access | Times Cited: 3
Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review
Patrick Jedlowski, Charisse Te, Robert J. Segal, et al.
American Journal of Clinical Dermatology (2018) Vol. 20, Iss. 1, pp. 97-114
Closed Access | Times Cited: 27
Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea
Min‐Suk Yang, Jin Yong Lee, Jayeun Kim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 8, Iss. 2, pp. 690-695.e2
Closed Access | Times Cited: 25
Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens–Johnson syndrome/toxic epidermal necrolysis
Qian Wang, Yunping Lan, Bo Qi, et al.
The Journal of Dermatology (2021) Vol. 48, Iss. 9, pp. 1394-1400
Closed Access | Times Cited: 20

Scroll to top